An Open Trial of Olanzapine in the Treatment of Patients with Psychotic Depression

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.13, Iss.3, 2001-09, pp. : 147-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olanzapine in the treatment of depression with psychotic features: A prospective open-label study

By Adli Mazda Wiethoff Katja Baethge Christopher Pfennig Andrea Stamm Thomas Bauer Michael

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 202-209

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Venlafaxin for the treatment of psychotic depression

By Licht R. Kassow P.

European Psychiatry, Vol. 13, Iss. 5, 1998-08 ,pp. : 276-277

Elsevier

Access to resources Recommend Favorite

Use of Olanzapine for Elderly Patients with Psychotic Disorders: A Review

By Madhusoodanan S.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 4, 2001-12 ,pp. : 201-213

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic effects of olanzapine and risperidone in patients with psychotic disorders

By Safa Mitra Sadr Saeed Delfan Bahram Saki Mandana Javad Tarrahi Mohammad

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 4, 2008-01 ,pp. : 299-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite

An Open-Label Trial of Sertraline for the Treatment of Major Depression in Primary Care

By Taragano F.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 11, Iss. 2, 1999-06 ,pp. : 67-71

Springer Publishing Company

Access to resources Recommend Favorite